These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma. Nagano M; Hatakeyama K; Kai M; Nakamura H; Yodoi J; Asada Y; Chijiiwa K HPB (Oxford); 2012 Sep; 14(9):573-82. PubMed ID: 22882193 [TBL] [Abstract][Full Text] [Related]
26. ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. Sun J; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S J Mol Histol; 2015 Feb; 46(1):57-65. PubMed ID: 25311765 [TBL] [Abstract][Full Text] [Related]
27. Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer. Kim J; Jang KT; Kim KH; Park JW; Chang BJ; Lee KH; Lee JK; Heo JS; Choi SH; Choi DW; Rhee JC; Lee KT Tumour Biol; 2010 Oct; 31(5):471-6. PubMed ID: 20517662 [TBL] [Abstract][Full Text] [Related]
28. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. Bektas S; Bahadir B; Ucan BH; Ozdamar SO Pathol Oncol Res; 2010 Dec; 16(4):569-77. PubMed ID: 20177845 [TBL] [Abstract][Full Text] [Related]
29. Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma. Ahn SW; Ahn AR; Ha SH; Hussein UK; Do Yang J; Kim KM; Park HS; Park SH; Yu HC; Jang KY Diagn Pathol; 2020 May; 15(1):63. PubMed ID: 32460791 [TBL] [Abstract][Full Text] [Related]
30. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390 [TBL] [Abstract][Full Text] [Related]
31. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer. Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335 [TBL] [Abstract][Full Text] [Related]
32. [Discussion on pT3 staging in TNM staging of AJCC 8(th) edition gallbladder carcinoma]. Yang FC; Li JD; Duan AQ; Bo ZY; Shen NJ; Zhu B; Yu WL; Cui LJ; Wang X; Yu LH; Yin L; Fu XH; Zhang YJ; Qiu YH Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):834-839. PubMed ID: 31694132 [No Abstract] [Full Text] [Related]
33. Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry. Wu W; Wang R; Liu H; Peng J; Huang D; Li B; Ruan J Med Oncol; 2009; 26(2):117-23. PubMed ID: 18665467 [TBL] [Abstract][Full Text] [Related]
34. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247 [TBL] [Abstract][Full Text] [Related]
35. Cluster of differentiation 24 expression is an independent prognostic factor of adverse outcome in cervical carcinoma. Huang LW; Lee CC Int J Gynecol Cancer; 2013 Feb; 23(2):325-30. PubMed ID: 23318912 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients. Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Sasaki E; Nagino M; Ebata T; Oda K; Arai T; Nishio H; Nimura Y Ann Surg; 2006 Jul; 244(1):99-105. PubMed ID: 16794394 [TBL] [Abstract][Full Text] [Related]
38. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer. Wang Q; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S Cancer Invest; 2016 Jul; 34(6):255-64. PubMed ID: 27389087 [TBL] [Abstract][Full Text] [Related]
39. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas. Liu Z; Yang Z; Xiong L; Li D; Zou Q; Yuan Y Int J Clin Oncol; 2020 Jul; 25(7):1346-1355. PubMed ID: 32249333 [TBL] [Abstract][Full Text] [Related]
40. CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells. Davidson B Hum Pathol; 2016 Dec; 58():123-127. PubMed ID: 27589896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]